arrow
M

Marinde J. G. Bond

Utrecht University
H指数:10
被引数:413

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases

ASO可视化摘要:循环肿瘤DNA对初始不可切除的RAS/RAF突变结直肠癌肝转移患者接受局部治疗后复发和生存的预后价值

2026-01-040
PRE
Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases

结合细胞外DNA片段组和肿瘤总体积可改善结直肠癌肝转移患者的预后预测和肿瘤反应评估

2025-12-160
OAAI
One-stage versus two-stage surgery for initially unresectable colorectal cancer liver metastases: post hoc analysis of the CAIRO5 trial

初始不可切除的结直肠癌肝转移:一阶段手术与两阶段手术的比较——CAIRO5试验的事后分析

2025-12-010
OAAI
Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases

循环肿瘤DNA对接受局部治疗的初始不可切除的RAS/RAF突变结直肠癌肝转移患者复发和生存的预测价值

2025-11-140
PRE
Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases:An ancillary study of the phase 3 CAIRO5 trial

总肿瘤体积可预测结直肠癌肝转移患者总生存期及诱导化疗反应:CAIRO5三期试验的辅助研究

2025-08-210
PREAI
Resectability assessment of colorectal liver metastases by an expert panel: Potential impact on hospitals referring patients for local treatment
EJSO
IF2.9
2025-06-010
PRE
Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation
2024-08-011
PRE
First-line systemic treatment in patients with initially unresectable colorectal cancer liver metastases (CRLM): Overall survival of the phase III CAIRO5 study of the Dutch Colorectal Cancer Group
2023-10-015
OAAI
ASO Visual Abstract: Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases-Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group
2023-05-300
PRE
Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group
2023-04-2810
OAAI
The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial
2023-04-018
OAAI
FOLFOX/FOLFIRI plus either bevacizumab or panitumumab in patients with initially unresectable colorectal liver metastases (CRLM) and left-sided and RAS/BRAFV600E wild-type tumour: Phase III CAIRO5 study of the Dutch Colorectal Cancer Group
2022-09-015
OA